(Q37207909)

18 August 2017

Development of type 1 diabetes in a patient treated with anti-TNF-alpha therapy for active rheumatoid arthritis (English)

1 reference

18 August 2017

0 references

0 references

0 references

1 reference

1 reference

C J Tack

1

1 reference

18 August 2017

F S Kleijwegt

series ordinal

2

1 reference

18 August 2017

P L C M Van Riel

series ordinal

3

1 reference

18 August 2017

B O Roep

series ordinal

4

1 reference

18 August 2017

14 May 2009

1 reference

18 August 2017

1 reference

18 August 2017

52

1 reference

18 August 2017

7

1 reference

18 August 2017

1442-1444

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1381-0

18 August 2017

0 references

cites work

The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688610

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688610

Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688610

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688610

Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688610

Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2688610

Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19440690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Validation of rheumatoid arthritis improvement criteria that include simplified joint counts

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19440690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-009-1381-0

1 reference

18 August 2017

1 reference

18 August 2017

1 reference